学术探索
学术期刊
新闻热点
数据分析
智能评审

APOLIPOPROTEIN-A AND APOLIPOPROTEIN-B (SF 100-400) METABOLISM DURING BEZAFIBRATE THERAPY IN HYPERTRIGLYCERIDEMIC SUBJECTS

被引：82
作者：
SHEPHERD, J
PACKARD, CJ
STEWART, JM
ATMEH, RF
CLARK, RS
BOAG, DE
CARR, K
LORIMER, AR
BALLANTYNE, D
MORGAN, HG
LAWRIE, TDV
机构：
[1] GLASGOW ROYAL INFIRM,DEPT MED CARDIOL,GLASGOW G4 0SF,SCOTLAND
[2] GLASGOW ROYAL INFIRM,DEPT DIETET,GLASGOW G4 0SF,SCOTLAND
[3] VICTORIA INFIRM,DEPT MED,GLASGOW G42 9TY,SCOTLAND
来源：
JOURNAL OF CLINICAL INVESTIGATION | 1984年 / 74卷 / 06期
关键词：
D O I：
10.1172/JCI111643
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：2164 / 2177
页数：14
相关论文
共 65 条
  • [51] METABOLISM OF APOLIPOPROTEINS A-I AND A-II AND ITS INFLUENCE ON HIGH-DENSITY LIPOPROTEIN SUBFRACTION DISTRIBUTION IN MALES AND FEMALES
    SHEPHERD, J
    PACKARD, CJ
    PATSCH, JR
    GOTTO, AM
    TAUNTON, OD
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1978, 8 (03) : 115 - 120
  • [52] SHEPHERD J, 1980, ATHEROSCLEROSIS, P591
  • [53] METABOLISM OF LOW-DENSITY LIPOPROTEIN IN ENDOGENOUS HYPERTRIGLYCERIDEMIA
    SIGURDSSON, G
    NICOLL, A
    LEWIS, B
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1976, 6 (02) : 151 - 158
  • [54] EFFECT OF CHLOROPHENOXYISOBUTYRATE ON METABOLISM OF ENDOGENOUS GLYCERIDES IN MAN
    SODHI, HS
    KUDCHODKAR, BJ
    HORLICK, L
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1971, 20 (03): : 309 - +
  • [55] THE METABOLISM OF VERY LOW-DENSITY AND INTERMEDIATE DENSITY LIPOPROTEINS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    SOUTAR, AK
    MYANT, NB
    THOMPSON, GR
    [J]. ATHEROSCLEROSIS, 1982, 43 (2-3) : 217 - 231
  • [56] STEVENS RE, 1975, ANALYT BIOCHEM, V65, P369
  • [57] EFFECTS OF BEZAFIBRATE ON RECEPTOR-MEDIATED AND RECEPTOR-INDEPENDENT LOW-DENSITY LIPOPROTEIN CATABOLISM IN TYPE-II HYPERLIPOPROTEINEMIC SUBJECTS
    STEWART, JM
    PACKARD, CJ
    LORIMER, AR
    BOAG, DE
    SHEPHERD, J
    [J]. ATHEROSCLEROSIS, 1982, 44 (03) : 355 - 365
  • [58] STORK H, 1975, LIPIDS LIPOPROTEINS, P485
  • [59] TAYLOR KG, 1980, EUR J CLIN INVEST, V10, P133, DOI 10.1111/j.1365-2362.1980.tb02072.x
  • [60] EFFECTS OF BEZAFIBRATE ON THE SERUM LIPOPROTEIN LIPID AND APOLIPOPROTEIN COMPOSITION, LIPOPROTEIN TRIGLYCERIDE REMOVAL CAPACITY AND THE FATTY-ACID COMPOSITION OF THE PLASMA-LIPID ESTERS
    VESSBY, B
    LITHELL, H
    HELLSING, K
    OSTLUNDLINDQVIST, AM
    GUSTAFSSON, IB
    BOBERG, J
    LEDERMANN, H
    [J]. ATHEROSCLEROSIS, 1980, 37 (02) : 257 - 269
1234567